latest news on glp 1 A wave of new #GLP1 drug options for type 2 #Diabetes and #Obesity was a major focus at #ADA2026. In the JAMA Medical podcast, Jennifer Abbasi interviews Rita Kalyani, MD, Fmr. FDA Commissioner weighs in
Description
Balances the gut microbiome*
These label expansions unlocked new pathways for coverage, and by early 2025 the proportion of Medicare patients with diabetes or obesity initiating GLP-1 therapy rose sharply
Discover features, costs, and GLP-1 medication options.
Learn what happens if you miss a dose of Ozempic, Wegovy or Mounjaro and how to safely get back on track.
